Operating Expenses - West Pharmaceutical Services Inc (NYSE:WST) - Alpha Spread

West Pharmaceutical Services Inc
NYSE:WST

Watchlist Manager
West Pharmaceutical Services Inc Logo
West Pharmaceutical Services Inc
NYSE:WST
Watchlist
Price: 297.24 USD -1.02% Market Closed
Market Cap: 22B USD
Have any thoughts about
West Pharmaceutical Services Inc?
Write Note

West Pharmaceutical Services Inc
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

West Pharmaceutical Services Inc
Operating Expenses Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
West Pharmaceutical Services Inc
NYSE:WST
Operating Expenses
-$422.7m
CAGR 3-Years
-4%
CAGR 5-Years
-8%
CAGR 10-Years
-5%
Thermo Fisher Scientific Inc
NYSE:TMO
Operating Expenses
-$9.8B
CAGR 3-Years
-4%
CAGR 5-Years
-7%
CAGR 10-Years
-8%
Danaher Corp
NYSE:DHR
Operating Expenses
-$8.5B
CAGR 3-Years
2%
CAGR 5-Years
-8%
CAGR 10-Years
-3%
Mettler-Toledo International Inc
NYSE:MTD
Operating Expenses
-$1.2B
CAGR 3-Years
-2%
CAGR 5-Years
-3%
CAGR 10-Years
-3%
Agilent Technologies Inc
NYSE:A
Operating Expenses
-$2B
CAGR 3-Years
2%
CAGR 5-Years
-1%
CAGR 10-Years
-11%
IQVIA Holdings Inc
NYSE:IQV
Operating Expenses
-$3.2B
CAGR 3-Years
0%
CAGR 5-Years
-2%
CAGR 10-Years
-14%

See Also

What is West Pharmaceutical Services Inc's Operating Expenses?
Operating Expenses
-422.7m USD

Based on the financial report for Jun 30, 2024, West Pharmaceutical Services Inc's Operating Expenses amounts to -422.7m USD.

What is West Pharmaceutical Services Inc's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-5%

Over the last year, the Operating Expenses growth was -6%. The average annual Operating Expenses growth rates for West Pharmaceutical Services Inc have been -4% over the past three years , -8% over the past five years , and -5% over the past ten years .

Back to Top